Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Zola

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Ophthalmology and Therapy|March 8, 2020
Resolution of Corneal Fibrosis After Descemet's Stripping Automated Endothelial Keratoplasty: A Case ReportMarta Zola, Jaeryung Kim, Myrsini Petrelli, et al.
Retina (Philadelphia, Pa.)|May 8, 2023
INDOCYANINE GREEN ANGIOGRAPHY OF TYPE 1 MACULAR NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION AND CENTRAL SEROUS CHORIORETINOPATHY REVEALS DIFFERENT DISEASE MECHANISMSMarta Zola, Elodie Bousquet, Catherine Favard, et al.
Retina (Philadelphia, Pa.)|January 26, 2018
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan RegimenIrmela Mantel, Ali Dirani, Marta Zola, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 30, 2017
Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasoneMarta Zola, Cristina Briamonte, Umberto Lorenzi, et al.
Journal of Clinical Medicine|October 13, 2021
Mid-Phase Hyperfluorescent Plaques Seen on Indocyanine Green Angiography in Patients with Central Serous ChorioretinopathyElodie Bousquet, Julien Provost, Marta Zola, et al.
The British Journal of Ophthalmology|October 17, 2019
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathyKhaled Romdhane, Marta Zola, Alexandre Matet, et al.
International Journal of Molecular Sciences|February 15, 2022
Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular TissuesMarta Zola, Dan Mejlachowicz, Raquel Gregorio, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 27, 2020
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatmentMarta Zola, Elisa D'Alessandro, Mohamed Sherif, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 17, 2015
Recent developments in the management of dry age-related macular degenerationElisa Buschini, Antonio M Fea, Carlo A Lavia, et al.
Journal of Ophthalmology|November 21, 2015
Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-UpAntonio Maria Fea, Giulia Consolandi, Marta Zola, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Ophthalmology and Therapy|March 8, 2020
Resolution of Corneal Fibrosis After Descemet's Stripping Automated Endothelial Keratoplasty: A Case ReportMarta Zola, Jaeryung Kim, Myrsini Petrelli, et al.
Retina (Philadelphia, Pa.)|May 8, 2023
INDOCYANINE GREEN ANGIOGRAPHY OF TYPE 1 MACULAR NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION AND CENTRAL SEROUS CHORIORETINOPATHY REVEALS DIFFERENT DISEASE MECHANISMSMarta Zola, Elodie Bousquet, Catherine Favard, et al.
Retina (Philadelphia, Pa.)|January 26, 2018
MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Risk Factor Evaluation for Individualized Treatment Need of Ranibizumab or Aflibercept According to an Observe-and-Plan RegimenIrmela Mantel, Ali Dirani, Marta Zola, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 30, 2017
Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasoneMarta Zola, Cristina Briamonte, Umberto Lorenzi, et al.
Journal of Clinical Medicine|October 13, 2021
Mid-Phase Hyperfluorescent Plaques Seen on Indocyanine Green Angiography in Patients with Central Serous ChorioretinopathyElodie Bousquet, Julien Provost, Marta Zola, et al.
The British Journal of Ophthalmology|October 17, 2019
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathyKhaled Romdhane, Marta Zola, Alexandre Matet, et al.
International Journal of Molecular Sciences|February 15, 2022
Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular TissuesMarta Zola, Dan Mejlachowicz, Raquel Gregorio, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 27, 2020
Refractory neovascular age-related macular degeneration: time-dependent changes of central retinal thickness with anti-VEGF treatmentMarta Zola, Elisa D'Alessandro, Mohamed Sherif, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 17, 2015
Recent developments in the management of dry age-related macular degenerationElisa Buschini, Antonio M Fea, Carlo A Lavia, et al.
Journal of Ophthalmology|November 21, 2015
Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-UpAntonio Maria Fea, Giulia Consolandi, Marta Zola, et al.
Pageof 3